ReviewMolecular neurobiology2026
Mechanisms of Action of FUNDC1 in Cerebral Ischemia-Reperfusion Injury.
Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral ischemia-reperfusion injury (CIRI) refers to a cascade of pathological events initiated by the restoration of blood flow to ischemic brain regions in patients with cerebral infarction. This process leads to mitochondrial dysfunction through mechanisms including oxidative stress, calcium overload, inflammation, and impaired energy metabolism. FUN14 domain containing 1 (FUNDC1), a key receptor protein involved in mitochondrial autophagy, plays a crucial protective role in CIRI by regulating mitophagy and maintaining mitochondrial quality control. This function is governed by the dynamic phosphorylation and dephosphorylation of FUNDC1, which finely modulate the activation and inhibition of mitophagy, thereby attenuating mitochondrial dysfunction. Moreover, FUNDC1 is implicated in mitochondrial fission, the clearance of unfolded proteins, mitochondrial iron metabolism, and inter-organelle communication, collectively contributing to the regulation of cellular metabolism and immune responses. Therefore, targeting FUNDC1-mediated mitophagy to restore mitochondrial quality control and reduce mitochondrial dysfunction represents a promising therapeutic strategy for CIRI. This review summarizes the role of FUNDC1 in mitochondrial dynamic homeostasis, inter-organelle communication, and CIRI, highlighting its potential as a therapeutic target.
Indexed as
Identifiers
42138761What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.